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Hydroa Vacciniforme Is Associated with Increased
Numbers of Epstein–Barr Virus–Infected cdT Cells
Yoji Hirai1, Takenobu Yamamoto1,2, Hiroshi Kimura3, Yoshinori Ito4, Kazuhide Tsuji1, Tomoko Miyake1,
Shin Morizane1, Daisuke Suzuki1, Kazuyasu Fujii1 and Keiji Iwatsuki1
Hydroa vacciniforme (HV) is a rare photosensitivity disorder of childhood associated with Epstein–Barr virus
(EBV)þ T-cell infiltration. We have summarized clinical manifestations of HV, and analyzed EBVþ T-cell subsets
as well as EBV DNA load in lymphocyte fractions, in comparison with hypersensitivity to mosquito bites (HMB),
an EBV-associated T/natural killer (NK) lymphoproliferative disorder. We found that 31 of 33 (93.9%) HV lesions
were composed of EBVþ T cells and reactive EBV cytotoxic T cells, without significant CD56þ cell infiltration,
whereas many CD56þ cells were present in 8 of 9 (88.9%) HMB lesions. Of 13 (20.6%) HMB patients with or
without HV, 12 (92.3%) showed increased percentages (432%) of NK cells in the peripheral blood, whereas in
the 16 patients with HV alone, 14 (87.5%) showed no increase. Of the 11 HV patients, 10 (90.9%) had increased
percentages (45%) of circulating gdT cells, with a mean value of 15.7 ± 2.9%, and the gdT-cell fractions
contained larger amounts of EBV DNA than non-gdT-cell fractions. A triple-labeling method revealed that all
three HV patients examined had increased percentages of EBERþ , T-cell receptor (TCR)gdþ , and TCRab cells.
Our observations indicate that HV is associated with increased numbers of EBVþ gdT cells, whereas HMB is
associated with EBVþ NK cells.
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INTRODUCTION
Epstein–Barr virus (EBV), a g-herpesvirus, has a preferential
tropism for B cells and epithelial cells. However, it has been
recognized that EBV likely infects and causes the proliferation
of not only B cells, but also T or natural killer (NK) cells, and
induces EBV-associated T/NK lymphoproliferative disorders
such as chronic active EBV infections and hemophagocytic
syndrome (Rezk and Weiss, 2007; Ohshima et al., 2008).
Previous studies have shown that cutaneous disorders such as
hydroa vacciniforme (HV) and hypersensitivity to mosquito
bites (HMB) are closely associated with EBV-infected T or
NK cells (Iwatsuki et al., 1997, 1999, 2006; Verneuil et al.,
2010).
HV is a photosensitivity disorder of childhood charac-
terized by herpetiform vesiculopapules on sun-exposed areas
such as face, ears, and dorsal surfaces of hands. The
cutaneous HV lesions contained various number of EBV-
encoded small nuclear RNA (EBER)þ T cells, together
with larger numbers of EBER cytotoxic T lymphocytes
(CTLs) expressing T-cell intracellular antigen (TIA)-1 and
granzyme B, whereas NK cells were absent or at background
levels in HV lesions (Morizane et al., 2005; Iwatsuki et al.,
2006).
Although no hematological abnormalities are usually
found in HV patients, EBV DNA load was increased in the
peripheral blood mononuclear cells (PBMCs; Iwatsuki et al.,
2006). In contrast, patients with severe HV usually present
with ulcerative cutaneous lesions with dense inflammatory
cell infiltrates reaching the subcutaneous tissue, and also
have markedly increased levels of EBV DNA load in the
peripheral blood. These patients often have complications
such as fever, leucopenia, liver damage, and lymphadenitis,
and may progress to fatal hemophagocytic syndrome and
HV-like T-cell lymphoma (Kimura et al., 2001, 2005;
Iwatsuki et al., 2006).
HMB is an EBV-associated T/NK lymphoproliferative
disorder characterized by intense local skin reactions and
systemic symptoms including high fever, lymphadenopathy,
hepatosplenomegaly, and hemophagocytic syndrome
(Tokura et al., 2001; Asada et al., 2005). These clinical
symptoms are induced by mosquito bites, insect bites, or
vaccination. Patients with HMB are usually associated with
NK cell lymphocytosis with latent EBV infection (Tokura
et al., 2001; Iwatsuki et al., 2006). HMB is often associated
with HV-like eruptions. It is intriguing to note that typical HV
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occurs worldwide, but the vast majority of patients with
severe HV and HMB have been reported in Asian countries
and Latin America (Magana et al., 1998; Kimura et al., 2001,
2005; Tokura et al., 2001; Cho et al., 2004; Asada et al.,
2005; Morizane et al., 2005; Nitta et al., 2005; Iwatsuki et al.,
2006; Rodriguez-Pinilla et al., 2010).
Although previous observations suggest that the occur-
rence of HMB is closely related to EBVþ NK cells (Tokura
et al., 2001), we still do not know which cell type has
a pivotal role in the development of HV. Recently, we and
other investigators have noticed that some patients with HV
may have increased numbers of EBVþ gdT cells in the
peripheral blood (Kimura et al., 2009; Tanaka et al., 2011).
In order to identify the T-cell subsets responsible for the
development of HV, we have analyzed phenotypes of
infiltrating cells in HV lesions, as well as the circulating
T-cell subsets harboring latent EBV infection, in comparison
with those in HMB.
RESULTS
Clinical manifestations of typical and severe HV
Of the 33 typical HV patients, 7 had complications with
oculomucosal involvement such as conjunctival hyperemia
and aphthous stomatitis, but neither internal nor hemato-
logical symptoms were observed in this group (Figure 1 and
Table 1). In severe HV patients (Figure 1), however, 7 of 15
patients presented with systemic symptoms, including fever,
lymph node swelling, liver damage, hemophagocytic syn-
drome, and other organ involvement such as esophageal
erosions, myocardial infiltration, and colon ulcer. Of the 15
HMB patients, 9 presented with HMB alone in the observa-
tion period, and 6 had a history of HV or coexistent HV
lesions. Many of the patients with HMB, with or without HV,
experienced systemic symptoms, and one patient progressed
to nasal-type NK lymphoma. In our series of patients with
severe HV and HMB, at least three patients died of disease
progression or intractable hemophagocytic syndrome, and
two patients recovered from HMB with a decrease in EBV
DNA load in the PBMCs.
EBV DNA load in typical and severe HV
EBV DNA levels in PBMCs were elevated in all 29 typical HV
patients, with a mean value of 18,500±5,100 copies per mg
DNA, ranging from 110 to 79,500 copies per mg DNA
(Figure 2). Severe HV patients had higher levels of EBV DNA
in the PBMCs than typical HV: 30,200±6,400 copies per mg
DNA, ranging from 450 to 101,000 copies per mg DNA, the
level of which was comparable to that in patients with HMB
with or without HV. There was no significant difference in
plasma EBV DNA levels between typical and severe HV:
2,400±820 copies per ml in typical HV versus 6,500±3,900
copies per ml in severe HV.
Cellular events in HV and HMB cutaneous lesions
Immunophenotypes of infiltrating cells in typical and severe
HV lesions were distinct from those in HMB lesions. In HV
lesions, B5 to 20% of the infiltrates were positive for EBER.
An NK cell marker, CD56, was absent or at a background
level in 31 of 33 (93.9%) cutaneous lesions. In the remaining
two cases with CD56þ cell infiltration, it was difficult to
identify the infiltrating cell type because a part of the
circulating sCD3þ T cells also expressed CD56 at various
degrees. In addition to the EBERþ cells, all HV lesions
contained dense infiltration of EBER cells expressing any
T-cell markers, including CD3e, CD45RO, CD4, and CD8, as
well as the majority of infiltrating cells carrying cytotoxic
molecules such as TIA-1 and granzyme B. Many CD3þ ,
T-cell receptor (TCR)b T cells were present in two HV
lesions examined (Supplementary Figure S1 online). In HMB
lesions, however, in addition to a small number of EBERþ
cells and many EBER CTLs, 8 of 9 HMB lesions contained
considerable numbers of CD56þ cells in the infiltrates.
One patient with coexistent HV and HMB lesions showed a
clear difference in CD56þ cell infiltration between lesions:
CD56þ cell infiltration was absent in the HV lesions, but
present in the HMB lesions (Figure 3).
Lymphocyte subsets in HV and HMB
No significant increase was observed in total lymphocyte
numbers in the peripheral blood of HV or HMB patients,
although the numbers of large granular lymphocytes (Figure 1)
were increased in some cases. The percentages of sCD3 and
CD56þ NK cells in PBMCs were increased (to 432%) in 12
of 13 (92.3%) HMB patients with or without HV, whereas no
such increase was observed in 14 of 16 (87.5%) patients with
HV alone (Figure 4a and b). The mean values of sCD3 and
CD56þ NK cells were 48.6±5.0% in the HMB group with or
without HV, and 11.0±2.5% in the HV group. In 10 of 11
(90.9%) HV patients examined, however, the percentages of
gdT-cell receptor (TCRgd)þ cells were increased (to 45%),
ranging from 7 to 36% of peripheral blood lympho-
cytes (Figure 4c). The mean percentage and absolute number
of TCRgdþ cells in all HV patients was 15.7±2.9%
(vs. 2.1±0.5% in normal individuals) and 266±108 ml,
respectively.
Clonality analysis of EBVþ cells
Of the 11 samples tested by Southern blot analysis using EBV
terminal repeat, EBV clonality was found in 8 samples,
biclonal in 2 samples, and polyclonal in 1 sample (Table 2).
In a patient with HMB associated with sCD3, CD8lowþ , and
CD56þ NK lymphocytosis, at least two different T-cell
clones showing a phenotype of EBVþ , sCD3þ , CD4þ , and
CD56þ / were found in the short-term culture with
50 unitsml–1 of recombinant IL-2 (Supplementary Figure S2
online). The two major EBVþ clones expressed Vb3 and
Vb13.2, respectively. These data, together with the results of
lymphocyte subsets, indicate that HMB patients, but not HV
patients, were associated with EBVþ NK cell lymphocytosis
with or without monoclonal proliferation, although the HMB
patients may also possess EBVþ T-cell clones.
EBVþ cdT-cell subset in HV
As PBMCs from HV patients showed elevated percentages of
TCRgdþ cells, we have focused on the EBVþ gdT-cell subset
in the development of HV. In fractionated lymphocyte
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subsets of cases 1, 3, and 4, the TCRgdþ cell fractions
contained higher EBV DNA load than the sCD3þ cell
fractions, including TCRgdþ as well as TCRabþ and other
cell types. In cases 5, 6, and 7, the TCRgdþ cell fractions
contained significantly higher EBV DNA load than the
TCRgd cell fractions (Table 2, *Po0.05).
In three representative HV cases examined, the triple-
labeling method detected EBERþ , TCRgdþ , and TCRab
cells in high percentages, ranging from 57 to 68% of EBERþ
cells, whereas EBERþ , TCRgd, and TCRabþ cells were
present in low percentages, ranging from 3 to 5% (Figure 4d).
No increase in EBERþ cells was found in sCD3 and CD19þ
B cells or in sCD3 and CD56þ NK cell fractions. In contrast,
6 HMB patients (cases 8, 9, 11, 12, 13, and 14 in Table 2),
with or without HV, had higher levels of EBV DNA load in
the CD56þ cell fractions than in the sCD3þ T-cell fractions.
Therefore, taken together with the results of the surface
phenotypes (Figure 4), most HV and HMB patients harbored
EBVþ gdT cells, and EBVþ NK cells, respectively, in the
peripheral blood.
DISCUSSION
Immunohistological examination revealed that the histogen-
esis of HV was distinct from that of HMB: HV lesions
were composed mainly of various percentages of EBERþ
cells, and EBER cytotoxic T cells without CD56 expression,
whereas HMB lesions contained considerable numbers of
CD56þ cells. As shown in Figure 3, a patient with coexistent
HV and HMB showed distinct cellular infiltrates: CD56þ
cells are absent in the HV lesions, but present in the HMB
lesions. HV lesions, therefore, are induced by EBERþ T cells
and a larger number of EBER CTLs, without apparent
involvement of NK cell infiltration. In contrast, 6 of 7 HMB
patients (Figure 4b) revealed increased percentages (432%)
of sCD3 and CD56þ NK cells in their peripheral blood,
whereas the percentages of sCD3 and CD56þ NK cells
were slightly increased in only 2 of 16 HV patients.
Furthermore, six HMB patients examined (Table 2) had
higher levels of EBV DNA load in the CD56þ cell fraction
than in sCD3þ T-cell fractions. These data, taken together
with previous reports (Morizane et al., 2005; Iwatsuki et al.,
Figure 1. Clinicopathological features of typical and severe HV. Cutaneous lesions of (a) typical hydroa vacciniforme (HV) and (b) severe HV, showing
(c) moderate lymphocytic infiltration in the upper dermis (hematoxylin/eosin stain), and (d) dense lymphocytic infiltration in the dermis and subcutaneous
tissue (bar¼ 500mm), respectively. (e, f) A large granular lymphocyte in peripheral blood cells, and a feature of hemophagocytosis in bone
marrow in a severe HV patient (May–Giemsa stain; bar¼ 10 mm).
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2006), indicate that cutaneous lesions of both typical and
severe HV are induced by EBERþ T cells, associated with a
larger number of EBER CTLs, without apparent involvement
of NK cell infiltration, whereas the occurrence of HMB
lesions is closely associated with increased numbers of
EBERþ NK cells (Tokura et al., 2001).
Some patients with HMB, however, presented with HV
simultaneously or at different periods in their clinical courses
(Nitta et al., 2005; Iwatsuki et al., 2006).
This overlapping might be because of the presence of
different EBVþ T- and NK-cell clones responsible for the
development of HV and HMB, respectively. Our hypothesis
Table 1. Clinical background of patients with HV and/or HMB
CD56+ cells in skin lesion Complications
Cases (M:F) Age (y)
EBER+ cells
in skin lesion
In HV
lesion
In HMB
lesion Fever
LN
swelling
Liver
damage HPS
Other organ
involvements
tHV 33 (16:17) 2–62 (mean 9.6) 1+ 17 0/20 0/0 0 0 0 0 0
2+ 8
3+ 3
4+ 0
sHV 15 (7:8) 4–77 (mean 18.5) 1+ 5 2/10 0/0 5 3 3 1 Esophageal erosions 1
2+ 5 Myocardial involvement 1
3+ 2 Colon erosions 1
4+ 3
HMB 9 (6:3) 5–22 (mean 12.2) 1+ 4 0/0 6/6 8 6 5 0 0
2+ 2
3+ 0
4+ 1
HV+HMB 6 (2:4) 3–34 (mean 12.3) 1+ 1 0/3 2/3 5 2 4 1 Nasal-type lymphoma 1
2+ 2
3+ 2
4+ 0
Total 63 (31:32) 2–77 (mean 12.4) 2/33 8/9 18 11 12 2
Abbreviations: EBER, Epstein–Barr virus (EBV)-encoded small nuclear RNA; F, female; HMB, hypersensitivity to mosquito bites; HPS, hemophagocytic
syndrome; HV, hydroa vacciniforme; LN, lymph node; M, male; sHV, severe hydroa vacciniforme; tHV, typical hydroa vacciniforme.
1+ Indicates 1% to o5% positivity in the infiltrates; 2+ indicates 5% to o25% positivity; 3+ indicates 25% to o50% positivity; and 4+ indicates X50%
positivity.
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Figure 2. Epstein–Barr virus (EBV) DNA load in patients with hydroa vacciniforme (HV) and/or hypersensitivity to mosquito bites (HMB) in the
peripheral blood mononuclear cells (PBMCs) and plasma. Patients with HV and/or HMB harbor significantly high levels of EBV DNA load in the (a) PBMCs and
(b) plasma, as compared with normal individuals (**Po0.01, ***Po0.001). Among the patient groups, patients with severe HV, HMB, and HVþHMB
show significantly higher levels of EBV DNA load in the PBMCs than patients with typical HV (*Po0.05; NS, not significant).
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may partly be supported by the fact that monoclonal proli-
feration of EBVþ cells was found in 8 of 11 blood samples,
but other 3 samples revealed biclonal or polyclonal proli-
feration. Furthermore, in one HMB patient with a dominant
NK-cell clone, we detected at least two different EBVþ T-cell
clones in the short-term culture. This phenomenon is similar
to the previous observations that established human T-cell
leukemia virus type 1 (HTLV-1)þ T-cell clones were not
always derived from the dominant clone in the peripheral
blood of the patients (Maeda et al., 1985). Our data suggest
that the EBVþ cell fractions of the patients may constitute a
mixture of one or a few dominant T/NK cell clones and some
minor clones, the condition of which might account for the
occurrence of various clinical symptoms (Kimura et al., 2001,
2005; Iwatsuki et al., 2006).
Although the development of HV lesions is closely
associated with EBVþ T-cell infiltration and reactive CTLs,
HV patients usually reveal no increase in absolute numbers of
sCD3þ T cells. In the T-cell subsets, however, 10 of 11
(90.9%) HV patients had increased percentages of TCRgdþ
cells in the PBMCs (Figure 4c), and higher levels of EBV DNA
in the TCRgdþ cell fractions than TCRgd or total sCD3þ
cell fractions (Table 2). Furthermore, EBERþ , TCRgdþ , and
TCRab cells were found in high percentages in three
patients with HV by our triple-labeling flow cytometry.
Therefore, our observations indicate that HV is pathogeni-
cally associated with increased numbers of circulating EBVþ
gdT cells. Because of technical limitation, there is no direct
evidence for the involvement of EBVþ gdT cells in HV
lesions. So far, many CD3þ , TCRb T cells without CD56
expression, namely non-abT cells, were present in two HV
lesions examined (Supplementary Figure S1 online). Further
research is also required to determine whether the sequential
pathomechanism in the development of HV is initial sun
exposure or photoprovocation, with the subsequent migra-
tion or activation of EBVþ gdT cells, followed by CTL
responses.
MATERIALS AND METHODS
Patients
Patients with ‘‘typical’’ HV fulfilled the following criteria: (1)
repetitive vesiculopapular eruptions on exposed areas including
Figure 3. Distinct cellular infiltrates in hydroa vacciniforme (HV) and hypersensitivity to mosquito bites (HMB). This patient (case 12 in Table 2) presented
with both (a) typical HV and (b) HMB lesions at the same time. (c) The HV lesion contains many T cells without CD56 expression (CD56 immunostain),
(d) but the HMB lesion is composed of many CD56þ cells. (e, f) A few EBERþ cells are observed in both lesions (in situ hybridization; bar¼ 50 mm).
(c, d) Note that both lesions contain peripheral nerves positive for CD56 (internal positive control).
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the face, lips, cheeks, and extensor surfaces of the hands and arms,
(2) histological features of reticulated degeneration of epidermis or
blister formation associated with dense lymphocytic infiltration, and
(3) the exclusion of hereditary photosensitivity disorders. In contrast,
patients with ‘‘severe’’ HV presented with one or more of the
following clinical and histopathological findings in addition to
the HV-like eruptions: (1) high-grade fever, (2) liver damage, (3)
ulcerative indurated lesions, and (4) edematous swelling of the
cheeks, eyelids, ears, and lips. According to previous reports (Tokura
et al., 2001; Asada et al., 2005), HMB was defined as ulceronecrotic
skin lesions with infiltration of EBERþ cells induced by mosquito
bites, insect bites, or vaccination.
A series of 63 patients with HV and/or HMB were enrolled in this
study. The median age of the patients was 8 years, with a range from
2 to 77 years, and the male to female ratio was 0.97. Skin biopsy
materials and blood samples were obtained for diagnosis, and used
in this study with the approval of ethics committee of Okayama
University. Patient consent for experiments was not required
because French laws consider human tissue left over from surgery
as discarded material. All biopsy specimens were examined by
routine hematoxylin/eosin-stained sections and immunostained
sections with antibodies to CD3e, CD4, CD8, CD20, CD45,
CD56, and cytotoxic molecules such as TIA-1 and granzyme B.
EBER was detected by in situ hybridization. According to the clinical
and histopathological findings, 63 patients were classified into four
groups: 33 patients with typical HV, 15 with severe HV, 9 with HMB
alone, and 6 with both HMB and HV.
For double immunostaining, two biopsy specimens from HV
were incubated with rabbit anti-human CD3 (Zymed Laboratories,
South San Francisco, CA) and monoclonal mouse anti-human TCRb
(clone: G-11, Santa Cruz Biotechnology, Santa Cruz, CA) at 4 1C
overnight. The specimens were then incubated with biotinylated
goat antimouse immunoglobulin (Dako, Glostrup, Denmark),
followed by FITC-conjugated F(ab’) fragment of goat anti-rabbit
IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) and
Cy3-conjugated streptavidin (Jackson ImmunoResearch Labora-
tories). The stained sections were observed using a fluorescence
microscope (Olympus BX50, Tokyo, Japan).
Assay for EBV DNA load
After analyzing 14 blood samples from the patients, we reclassified
them into three groups: HV alone (n¼ 7), HMB alone (n¼ 3), and
HVþHMB (n¼ 4), because of the overlapping clinical symptoms on
the blood sampling. For EBV DNA load analysis, DNA was extracted
from 1 106 PBMCs using a QIAamp Blood Kit (Qiagen, Hilden,
Germany), and real-time quantitative PCR was performed with a
fluorogenic probe. The EBV DNA load was calculated as copy
number per mg of PBMC DNA.
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Figure 4. Lymphocyte subsets in peripheral blood mononuclear cells (PBMCs) from patients with hydroa vacciniforme (HV) and/or hypersensitivity to
mosquito bites (HMB), and flow cytometric analysis on surface immunophenotypes and nuclear Epstein–Barr Virus-encoded small nuclear RNA (EBER).
(a–c) Lymphocyte subsets in PBMCs from patients with HV and/or HMB. (a, b) The natural killer (NK) cell (sCD3 and CD56þ ) percentages are significantly
higher in a patient group of HMB than in a group of HV alone, indicating that HMB is closely associated with NK cell lymphocytosis. (c) The percentages of
T-cell receptor (TCR)gdþ cells are increased in HV, (a) without significant increase in sCD3þ T-cell percentages (**Po0.01, ***Po0.001). (d) Flow cytometric
analysis on surface immunophenotypes and EBER. The majority of EBERþ cells (red) in HV express a surface phenotype of CD3þ , TCRab, TCRgdþ , CD4,
CD8, and CD56 (case 1 in Table 2). The color reproduction of this figure is available in the Journal of Investigative Dermatology online.
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Lymphocyte subset analysis
To determine the cell types harboring EBV genomes, PBMCs were
fractionated into CD3þ , CD19þ , CD56þ , TCRabþ , and TCRgdþ
cells using an immunobead method (IMag Cell Separation System;
Becton Dickinson, Franklin Lakes, NJ) with 97–99% purity. The EBV
DNA load of the fractionated cells was analyzed by real-time
quantitative PCR, and compared with that of the PBMCs as a whole.
Clonality analysis of EBVþ cells
The clonality of EBV was determined using Southern blotting with a
terminal repeat probe as described previously (Raab-Traub and
Flynn, 1986). PBMCs cultured in the presence of 50 unitsml–1 of
recombinant IL-2 were assayed for TCR Vb expression by flow
cytometry (IOTest Beta Mark TCR-Vb Repertoire Kit; Beckman
Coulter, Miami, FL), and examined for EBER using cytosmears.
Labeling for EBER by fluorescence in situ hybridization and
immunophenotypes
Triple labeling for nuclear EBER and surface phenotypes was
performed as described previously (Kimura et al., 2009). Briefly,
cells were stained with the appropriate antibodies before fixation
and in situ hybridization. After fixation with 1% (vol/vol) acetic acid
in 4% paraformaldehyde/phosphate-buffered saline for 40minutes at
4 1C and washing, the cells were resuspended in 45 ml of hybridiza-
tion solution containing 12 nmol l–1 of the FITC-labeled EBER peptide
nucleic acid probe, and hybridized for 1 hour at 56 1C. To enhance
fluorescence and photostability, the Alexa Fluor 488 Signal
Amplification Kit (Molecular Probes, Invitrogen, Carlsbad, CA) was
used. Stained cells were analyzed using a FACSCalibur flow cytometer
and CellQuest software, version 5.2.1 (Becton Dickinson).
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6/F/23 3 tHV Monoclonal 84 5 TCRgd PBC 101 2,900
7/M/3 1 tHV ND 85 3 TCRgd PBC 870 31,600
8/M/5 4 HMB Monoclonal 15 10 11,288 18,423 86,361 ND
9/M/8 3 HMB Polyclonal 25 50 7,428 17,083 89,352 ND
10/M/9 6 HMB Monoclonal 37 51 TCRgd PBC 90,000 5,800
11/M/34 20 HV+HMB Monoclonal 60 37 4,250 16,200 30,577 ND
12/F/3 2 HV+HMB Biclonal 45 32 330 3,300 23,400 ND
13/F/6 2 HV+HMB Monoclonal 15 60 3,288 1,866 35,252 ND
14/M/4 3 HV+HMB Monoclonal 22 65 21,352 3,200 171,741 ND
Abbreviations: EBV, Epstein–Barr virus; F, female; HMB, hypersensitivity to mosquito bites; HV, hydroa vacciniforme; M, male; ND, not done; PBC,
peripheral blood cell; PBMC, peripheral blood mononuclear cell; sHV, severe HV-like eruptions associated with high-grade fever, liver damage, indurated
nodules, high titer against EBV, high EBV DNA copy number, and high mortality compared with typical HV; TCR, T-cell receptor; tHV, typical HV; ?, no
data.
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